KRBA1 activators are a category of chemical compounds that engage a specific biological pathway by targeting and activating the KRBA1 protein. The KRBA1 protein, known in full as Keap1-Nrf2 Regulating Bromodomain-Associated 1, plays a crucial role within the cellular environment, primarily involved in the regulation of transcription factors, which are pivotal for controlling the expression of genes. By binding to this protein, KRBA1 activators influence the activity of pathways that are involved in the modulation of various cellular processes. These activators can be designed to exhibit high specificity, binding affinity, and potency towards the KRBA1 protein, affecting its interaction with other molecules within the cell.
The molecular structure of KRBA1 activators often includes a pharmacophore, the part of the molecule that is responsible for its biological activity, which enables it to bind precisely to the KRBA1 protein. The design of these activators might incorporate an array of functional groups that can form non-covalent interactions such as hydrogen bonds, van der Waals forces, and hydrophobic interactions with the target protein, thereby stabilizing the activator-KRBA1 complex. The specificity and selectivity of these compounds are of paramount importance, as they determine the exactitude with which these molecules activate the KRBA1 protein without off-target effects. Research and development in this chemical class focus on elucidating the precise mechanisms of action, the optimization of the molecular interactions, and understanding the structure-activity relationships (SAR) that govern the efficacy and specificity of the activators within biological systems.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum kinase inhibitor, but it may selectively modulate signaling pathways to indirectly enhance the functional activity of KRBA1. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a JNK activator that can influence the c-Jun N-terminal kinase pathway, potentially affecting other signaling molecules and pathways that could lead to the functional activation of KRBA1. | ||||||